Larson Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.48M | Sell |
11,716
-349
| -3% | -$46K | 0.04% | 295 |
|
|
2026
Q1 | $1.68M | Buy |
12,065
+2,664
| +28% | +$373K | 0.05% | 253 |
|
|
2025
Q4 | $1.15M | Buy |
9,401
+1,088
| +13% | +$132K | 0.04% | 296 |
|
|
2025
Q3 | $923K | Sell |
8,313
-4,859
| -37% | -$552K | 0.03% | 325 |
|
|
2025
Q2 | $1.46M | Buy |
13,172
+1,696
| +15% | +$180K | 0.06% | 248 |
|
|
2025
Q1 | $1.29M | Buy |
11,476
+2,271
| +25% | +$234K | 0.06% | 236 |
|
|
2024
Q4 | $850K | Buy |
9,205
+1,370
| +17% | +$123K | 0.04% | 269 |
|
|
2024
Q3 | $657K | Buy |
7,835
+3,464
| +79% | +$264K | 0.04% | 287 |
|
|
2024
Q2 | $300K | Buy |
4,371
+2,878
| +193% | +$192K | 0.02% | 361 |
|
|
2024
Q1 | $109K | Buy |
1,493
+276
| +23% | +$21.2K | 0.01% | 523 |
|
|
2023
Q4 | $98.6K | Buy |
1,217
+18
| +2% | +$1.4K | 0.01% | 488 |
|
|
2023
Q3 | $89.8K | Buy |
1,199
+156
| +15% | +$12K | 0.01% | 473 |
|
|
2023
Q2 | $80.3K | Buy |
1,043
+84
| +9% | +$6.7K | 0.01% | 454 |
|
|
2023
Q1 | $79.5K | Sell |
959
-163
| -15% | -$13.5K | 0.01% | 461 |
|
|
2022
Q4 | $96.3K | Buy |
1,122
+233
| +26% | +$18.5K | 0.01% | 409 |
|
|
2022
Q3 | $55K | Buy |
889
+60
| +7% | +$3.78K | 0.01% | 450 |
|
|
2022
Q2 | $51K | Buy |
829
+15
| +2% | +$929 | 0.01% | 367 |
|
|
2022
Q1 | $48K | Buy |
814
+9
| +1% | +$575 | 0.01% | 383 |
|
|
2021
Q4 | $58K | Sell |
805
-79
| -9% | -$5.44K | 0.01% | 359 |
|
|
2021
Q3 | $62K | Sell |
884
-162
| -15% | -$11.4K | 0.01% | 264 |
|
|
2021
Q2 | $72K | Buy |
1,046
+161
| +18% | +$10.8K | 0.02% | 219 |
|
|
2021
Q1 | $57K | Buy |
885
+178
| +25% | +$11.5K | 0.02% | 231 |
|
|
2020
Q4 | $41K | Buy |
707
+9
| +1% | +$543 | 0.01% | 245 |
|
|
2020
Q3 | $44K | Buy |
698
+2
| +0.3% | +$139 | 0.02% | 218 |
|
|
2020
Q2 | $54K | Sell |
696
-87
| -11% | -$6.67K | 0.03% | 187 |
|
|
2020
Q1 | $59K | Buy |
783
+148
| +23% | +$10.2K | 0.04% | 149 |
|
|
2019
Q4 | $41K | Sell |
635
-191
| -23% | -$12.4K | 0.02% | 166 |
|
|
2019
Q3 | $52K | Buy |
826
+194
| +31% | +$12.7K | 0.03% | 145 |
|
|
2019
Q2 | $43K | Buy |
632
+13
| +2% | +$855 | 0.03% | 134 |
|
|
2019
Q1 | $40K | Buy |
619
+6
| +1% | +$399 | 0.03% | 127 |
|
|
2018
Q4 | $38K | Buy |
+613
| New | +$42.8K | 0.04% | 123 |
|
Other funds holding GILD
Larson Financial Group's GILD Position: Q2 2026 in Review
Larson Financial Group reduced its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, selling an estimated $46K and leaving 11,716 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #295.
Larson Financial Group first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.68M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Larson Financial Group held 11,716 shares of Gilead Sciences worth $1.48M as of Q2 2026.
- Larson Financial Group sold 349 Gilead Sciences shares in Q2 2026, an estimated $46K.
- Gilead Sciences made up 0.04% of Larson Financial Group's portfolio in Q2 2026, its #295 holding.
- Larson Financial Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
- Larson Financial Group's Gilead Sciences position peaked at $1.68M in Q1 2026.
- 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.